Scott Rocklage is a doctor and American businessman who possesses more than 30 years of experience in the healthcare management industry. his knowledge of healthcare has lead to him holding several leadership positions within healthcare companies.
some of which include Cubist Pharmaceuticals, Nycomed Salutar, Salutar, and Catalytica. He is largely credited with getting three U.S. New Drug Applications approved by the FDA as well as entering may drug candidates into clinical trials.
In 2003 Dr. Rocklage joined life science-based venture capital firm 5AM Ventures. Within a years time he was promoted to managing partner. 5AM Ventures, promptly named, is still in the early stages of its overall development. Read more: Scott Racklage | Bloomberg
Dr. Scott Rocklage earned his B.S. in Chemistry from the University of California, Berkeley and would go on to later become an alumni of MIT, a prestigious institute of technology located in Massachusetts. He received his PhD in Chemistry from the high profile school.
Dr. Rocklage was really able to work out what he wanted to do with his life while attending MIT.
Despite all of his accomplishments Dr. Rocklage is not one to rest on his laurels. He constantly studies new areas of life science and how he can implement his findings into everyday life. He works with entrepreneurs with expertise in various fields on very promising ideas. Dr. Rocklage has invented or co-invented at least 30 U.S patents and 100 peer-reviewed publications.
Dr. Rocklage is constantly asked how he has been able to successfully grow multiple businesses throughout his career. He answers with saying staying true to the business. Never let your business evolves to the point that it is unrecognizable. Most times it’s best to stay the course rather than stray and try something completely different.
Dr. Rocklage is the current Board Chairman of Rennovia, Kinestral, and Cidara as well as, Epirus, and Pulmatrix.